Epigenomics AG / Key word(s): Change in Forecast/MiscellaneousEpigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act 20-March-2023 / 20:19 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group […]
Author: mark
20. March 2023
Epigenomics AG: Adjustment of guidance and notice of loss pursuant to sec. 92 para. 1 of the German Stock Corporation Act
Read more
10. March 2023
Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations)
EQS-News: Epigenomics AG / Key word(s): Miscellaneous/Restructure of CompanyEpigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with additional post-admission obligations) 10.03.2023 / 09:37 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Revocation of admission to the Prime Standard (sub-segment of the regulated market with […]
15. February 2023
Epigenomics resolves on restructuring to minimize costs
Epigenomics AG / Key word(s): Restructure of Company/Financing Epigenomics resolves on restructuring to minimize costs 15-Feb-2023 / 11:13 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG. The issuer is solely responsible for the content of […]
15. February 2023
Epigenomics decides to restructure to minimize costs
EQS-News: Epigenomics AG / Key word(s): Restructure of Company/FinancingEpigenomics decides to restructure to minimize costs 15.02.2023 / 11:18 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics decides to restructure to minimize costs Berlin (Germany) and San Diego, CA (U.S.A.) February 15, 2023 – The Executive Board of Epigenomics AG (Frankfurt Prime […]
15. February 2023
Epigenomics resolves on restructuring to minimize costs
Epigenomics AG / Key word(s): Restructure of Company/FinancingEpigenomics resolves on restructuring to minimize costs 15-Feb-2023 / 11:13 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Epigenomics […]
27. January 2023
Epigenomics AG: Resignation of the Chairman of the Supervisory Board Heino von Prondzynski
Berlin, January 27, 2023 -The Chairman of the Supervisory Board of Epigenomics AG, Heino von Prondzynski, informed the Boards today that he will resign from his mandate effective March 31, 2023, for health reasons and will leave the Supervisory Board at that time. Mr. von Prondzynski has been Chairman of the Supervisory Board of Epigenomics […]